1 1 Sandalwood Medical Limited 08804707 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the provision of medical consultancy services. Digita Accounts Production Advanced 6.30.9574.0 true 08804707 2024-01-01 2024-12-31 08804707 2024-12-31 08804707 bus:OrdinaryShareClass1 2024-12-31 08804707 core:RetainedEarningsAccumulatedLosses 2024-12-31 08804707 core:ShareCapital 2024-12-31 08804707 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08804707 bus:SmallEntities 2024-01-01 2024-12-31 08804707 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08804707 bus:FilletedAccounts 2024-01-01 2024-12-31 08804707 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08804707 bus:RegisteredOffice 2024-01-01 2024-12-31 08804707 bus:Director1 2024-01-01 2024-12-31 08804707 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 08804707 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08804707 bus:Agent1 2024-01-01 2024-12-31 08804707 countries:AllCountries 2024-01-01 2024-12-31 08804707 2023-01-01 2023-12-31 08804707 2023-12-31 08804707 bus:OrdinaryShareClass1 2023-12-31 08804707 core:RetainedEarningsAccumulatedLosses 2023-12-31 08804707 core:ShareCapital 2023-12-31 08804707 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 08804707

Sandalwood Medical Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 December 2024

 

Sandalwood Medical Limited

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

Sandalwood Medical Limited

Company Information

Director

Dr Sachithevi Sivananthan

Registered office

Unit 1 Barons Court
Graceways
Whitehills Business Park
Blackpool
Lancashire
FY4 5GP

Accountants

Rawcliffe & Co Limited
Chartered accountantsUnit 1 Barons Court
Graceways
Whitehills Business Park
Blackpool
Lancashire
FY4 5GP

 

Sandalwood Medical Limited

(Registration number: 08804707)
Abridged Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Current assets

 

Stocks

257

783

Cash at bank and in hand

 

1,315

683

 

1,572

1,466

Creditors falling due within one year

(25,164)

(25,488)

Total assets less current liabilities

 

(23,592)

(24,022)

Accruals and deferred income

 

(693)

(660)

Net liabilities

 

(24,285)

(24,682)

Capital and reserves

 

Called up share capital

4

100

100

Retained earnings

(24,385)

(24,782)

Shareholders' deficit

 

(24,285)

(24,682)

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 1 May 2025
 

.........................................
Dr Sachithevi Sivananthan
Director

   
     
 

Sandalwood Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Unit 1 Barons Court
Graceways
Whitehills Business Park
Blackpool
Lancashire
FY4 5GP
United Kingdom

These financial statements were authorised for issue by the director on 1 May 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Sandalwood Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2024

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Sandalwood Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2024

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100